The Valley Desk

NCT05476770 · Interventional trial

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Overall registry status Recruiting

Phase 1

Conditions ALL, AML, Acute Undifferentiated Leukemia, BPDCN, Hematologic Malignancy, Hodgkin Lymphoma, Lymphoblastic Lymphoma, Lymphoma, B-Cell, Lymphoma, T-Cell, MDS, Mixed Phenotype Acute Leukemia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov